SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-20-308630
Filing Date
2020-12-03
Accepted
2020-12-02 19:21:59
Documents
2
Group Members
ERIC D. ANDERSENWESTERN STANDARD PARTNERS, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d12485dsc13da.htm SC 13D/A 69184
2 EX-99.1 d12485dex991.htm EX-99.1 3983
  Complete submission text file 0001193125-20-308630.txt   74931
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Subject) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86778 | Film No.: 201365233
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5900 WILSHIRE BLVD SUITE 650 LOS ANGELES CA 90036
Business Address 5900 WILSHIRE BLVD SUITE 650 LOS ANGELES CA 90036 3107465639
Western Standard LLC (Filed by) CIK: 0001517666 (see all company filings)

IRS No.: 133604093 | State of Incorp.: CA
Type: SC 13D/A